14 Bacteria utilize CRISPR-Cas adaptive immune systems for protection from 15 bacteriophages (phages), and some phages produce anti-CRISPR (Acr) proteins 16 that inhibit immune function. Despite thorough mechanistic and structural 17 information describing the mode-of-action for Acr proteins, how they are deployed 18 by phages during infection is unknown. Here, we show that Acr production does 19 not guarantee phage replication, but instead, CRISPR-Cas neutralization and 20 phage infections fail when phage population numbers are too low. Failing 21 infections can be rescued by kin phages acting as Acr producers, demonstrating 22 that infections succeed if a sufficient Acr dose is contributed to a single cell by 23 multiple phage genomes. The production of Acr proteins by phage genomes that 24 fail to replicate leave the cell immunosuppressed, assisting other phages in the 25 population. These observations apply generally to both Cas3 and Cas9-based 26 adaptive immunity. This "cooperative phage" mechanism for CRISPR-Cas 27 inhibition demonstrates inter-virus cooperation that may find parallels in other 28 host-parasite interactions. 29 30 73 Despite a detailed mechanistic understanding, however, it is unknown how anti-CRISPR
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Concentration-dependent success of CRISPR-Cas neutralization during phage infection 148 could be caused by an excess of phage DNA targets that overwhelm a cell by titrating 149 Csy complexes away from other phages, or by the contribution of Acr proteins from 150 multiple phage genomes in a single cell. To experimentally address these models, we 151 genetically modified phages to render them non-replicative, thus allowing the 152 independent titration of a subset of phages in the population. The immunity region from 153 heteroimmune phage JBD30 ( Figure S4A ) was introduced into DMS3m phages, 154 generating a hybrid phage, whose replication could be prevented by the overexpression 155 of the JBD30 C repressor (gp1, Figure S4B ). In the presence of the JBD30 C repressor, 156 high doses of the hybrid phage did not replicate, confirming the efficacy of gp1 157 overexpression ( Figure S4C ). This enabled the mixing of replicative and non-replicative 158 phages, the latter acting as sacrificial genome and Acr donor, to assess the mechanism 159 for the observed concentration dependency.
161
In the presence of non-replicating phages encoding acrIF1, and possessing the same 162 five DNA target sequences, we observed a striking rescue effect, where this phage 163 assisted in CRISPR-Cas neutralization, enabling DMS3m acrIF1 ( Figure 2G ) and 164 DMS3m acrIF4 ( Figure 2H ) to replicate at input concentrations that are unsuccessful in the 165 absence of the "helper phage". Although the input of helper phages was at a modest 166 level (10 6 PFU, MOI = 0.2), this enabled the replicative phage to achieve an increase of 167 phage titers by 4-5 orders of magnitude. However, this helping effect was not observed 168 when the replicative phage did not encode an AcrIF protein ( Figure 2I ), or when the non-169 replicating phage produced acrIE3 ( Figure 2H-2I ). Additionally, any potential lysogens 170 formed by the DMS3m hybrid helper phage in this experiment would not have amplified 171 the replicating phage, as these lysogens remain resistant to superinfection ( Figure S4D ).
172
These data demonstrate that Csy complex titration by infecting phage genomes alone 173 does not appear to be a significant "anti-CRISPR" factor in the outcome of phage 174 replication or bacterial survival. Instead, the determinant of phage replicative success is 175 the concentration of Acr proteins reached in single cells, which is achievable by Acr 176 production from independent phage genomes. This suggests that multiple phage 177 genomes can contribute to the "immunosuppression" of a single host by contributing All phages encoding Acr proteins that infect P. aeruginosa are naturally temperate, and 183 can form lysogens by integrating into the bacterial genome. We therefore measured the 184 impact of CRISPR and Acr proteins on lysogeny establishment during a single round of 185 infection. While previous experiments examined cumulative phage replication in the lytic 186 cycle over many hours, assaying lysogen formation over a short time frame is ideal for 187 understanding the initial events that determine phage genome survival or cleavage.
188
Additionally, lysogeny provides a direct readout for phage genome survival (i.e. an 189 integrated prophage), while in lytic replication, phage survival leads to a dead cell that 190 cannot be recovered. For these experiments, we selected the weak AcrIF4 protein as it 191 provided the largest dynamic range of inefficiency in a single round of infection.
193
We generated derivatives of DMS3m acrIF4 and DMS3m acrIE3 marked with a gentamicin 194 resistance cassette at the end of the genome, replacing a nonessential gene, gp52. This 195 allowed the independent titration of two distinct and replicative phage populations and 196 the selection and analysis of stable lysogens after the experiment. These phages were 197 used to infect ∆CRISPR cells (0sp) for a time span less than a single round of infection 198 (50 minutes, Figure S5 ), and the number of gentamicin resistant lysogens assessed. In 199 the absence of CRISPR selection, a linear increase in the number of lysogens with 200 increasing MOI was observed, over ~4 orders of magnitude ( Figure 3A -3B, circles). In 201 the presence of spacers targeting DMS3m (5sp), CRISPR reduced the efficiency of 202 lysogeny (EOL, compared to 0sp) for the weak acr phage DMS3m acrIF4 , to such a degree 203 that lysogeny was undetectable at low MOIs, and impaired by 100-1000-fold at higher 204 MOIs ( Figure 3A , triangles). DMS3m acrIF4 demonstrated concentration dependence for 205 successful lysogeny, with EOL values below or at the limit of detection for lower MOIs, 206 increasing to EOL = 0.01 at higher MOIs ( Figure 3C ). Phage DMS3m acrIE3 formed no 207 lysogens at all input concentrations tested ( Figure 3B, 3D ), demonstrating the utility of an 208 acrIF gene for lysogen establishment.
210
We hypothesized that if the concentration dependence for CRISPR neutralization during 211 lysogeny could also be explained by phage cooperation, the "below-the-threshold" 212 concentration of 10 3 LFU DMS3m acrIF4 could be rescued by the addition of helper phages 213 in trans. In accordance with this prediction, infection of the 5sp strain with a mixture of 214 DMS3m acrIF4 gp52::gent phages (10 3 LFU) and 10 7 PFU of unmarked helper phages magnitude with helper phage DMS3m acrIF1 and the DMS3m acrIF4 helper phage increased 217 EOL by 1 order of magnitude ( Figure 3E ). No such increase in lysogeny was observed 218 for a phage without an acrIF gene, DMS3m acrIE3 gp52::gent ( Figure 3F ). The addition of 219 helper phages DMS3m acrIE3 , or an escaper phage DMS3m acrIE3 * had no effect on the 220 EOL of the marked DMS3m acrIF4 phage, demonstrating that the helper phage must be an 221 Acr-producer.
223
To determine the outcome of this co-infection experiment we used the resulting lysogens 
248
and engineered a DMS3m phage to express a previously identified stoichiometric inhibitor of SpyCas9, AcrIIA4 (Dong et al., 2017; Rauch et al., 2017) . In this entirely 250 heterologous experiment, we observed the same inefficiency for a phage relying on an 251 Acr protein. Spot-titration of phage lysates on a strain expressing a single guide RNA 252 (sgRNA) targeting DMS3m decreased the titer of DMS3m acrIE3 by many orders of 253 magnitude, while DMS3m acrIIA4 was protected ( Figure 4A ). However, quantification of the 254 efficiency of plaquing again revealed that relying on an Acr protein for replication is 255 imperfect, with an EOP = 0.4 ( Figure 4B ). In lytic replication infection experiments,
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DMS3m acrIIA4 displayed concentration-dependent replication in the presence of CRISPR 257 targeting ( Figure 4C ), while DMS3m acrIE3 did not replicate in a concentration-dependent 258 manner ( Figure 4D ). In the absence of CRISPR-Cas targeting, however, both phages 259 replicated robustly ( Figure 4E , 4F). To determine whether this concentration dependence 260 to Cas9 inhibition was also a result if insufficient intracellular Acr dose, a non-replicative 261 hybrid DMS3m AcrIIA4 phage was generated and used as a helper during infection. Indeed, 262 increased delivery of AcrIIA4 to cells allowed DMS3m AcrIIA4 to replicated robustly from a 263 concentration that was previously unsuccessful ( Figure 4G ), demonstrating phage 264 cooperation to neutralize CRISPR-Cas9. Utilizing a single spacer sequence in this 265 experiment, allowed for phage escape mutations to be more prevalent, and we observed 266 that DMS3m acrIE3 could also be helped by increased doses of AcrIIA4 from the phage 267 population ( Figure 4H 
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Here we demonstrate that the necessary intracellular concentration of an anti-immunity 275 protein to achieve inactivation of cellular immunity depends on the relative strengths of 276 both the inhibitor and the immunity pathway, which dictates the number of infecting 277 viruses required in the population. We conclude that a single cell can become 278 immunosuppressed by anti-immune protein contributions from independent infection 279 events. In the absence of viral replication, these infection events serve to contribute to 280 the inactivation of cellular immunity, thus enhancing the probability of successful 281 infection events in the future ( Figure 5 ). We expect that cooperation of this sort is necessary when the immune process acts rapidly and irreversibly on the infecting viral 283 genome, as CRISPR-Cas immunity does.
285
The ability of phages to replicate in the lytic cycle or establish lysogens is impacted 286 dramatically by the number of phages in the population. To demonstrate phage-phage 287 cooperation for the deployment of Acr proteins, three distinct genetic strategies were 288 used, allowing the independent titration of phages encoding a defined Acr protein: i) non- 
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The key result here is the observation that phages can remodel their host cell, even in 304 the absence of a replicating or integrated genome. It has long been known that 305 integrated prophages modulate host phenotypes via gene expression, including 306 superinfection exclusion, toxin production, and the production of Acr proteins (Bondy- 308 Waldor and Mekalanos, 1996; Weigle and Delbruck, 1951) . Although less commonly 309 described, there is also precedent for lytic phages to impact an interaction with other 310 phages during replication. The Imm protein produced by the phage T4 prevents other 311 phages in the environment from infecting the cell that one phage is currently replicating 312 within (Lu and Henning, 1989) . This has been attributed to preventing superinfection and 313 the potential disruption of the carefully timed phage replication cycle. This supports a 314 conclusion that co-and/or re-infections are a common occurrence in nature. However, 315 here, we propose new model of phage-induced host remodeling; that transient, cleared genomes produce proteins that could enable future infections, by inactivating defense.
317
This phenomenon would be evolutionarily advantageous in a clonal phage population,
318
where all are providing Acr proteins to neutralize CRISPR, and as shown in Figure 2I , a 319 phage not making an AcrIF protein was unable to "cheat" despite the presence of helper 320 phages in the population.
322
A distinct, but notable observation from this work is that not all Acr proteins operate at 323 full strength, as AcrIF4 and AcrIF5 provide weak protection to their phage genome.
324
However, encoding these genes still provides a significant advantage to the phage, 325 compared to lacking them entirely. Because the mechanism of action for AcrIF5 is still 326 unknown, we focused on AcrIF4, demonstrating that its affinity for the Csy complex is 327 orders of magnitude lower than stronger Acr proteins like AcrIF1. At present, however,
328
we lack an explanation for why a weak Acr protein would be utilized by phages if 329 stronger variants are available. AcrIF1 was selected as a model strong Acr protein 330 because of its comparable mechanism of action to AcrIF4 (i.e. Csy complex binding). We 331 consider AcrIF1 to be representative for other strong Acr proteins (AcrIF2, F3, F6, F7) as 332 phages encoding them had similar efficiencies of plaquing, and we therefore expect 333 similar threshold concentrations. Going forward, we speculate that the strongest Acr 334 proteins would be enzymatic in nature, allowing rapid and efficient inactivation of 335 CRISPR complexes in a sub-stoichiometric manner, although no such Acr mechanism 336 has been discovered. While not an enzyme, the recent demonstration of the AcrIIC3 337 protein inactivating two Cas9 proteins at the same time would likely be a more efficient 338 path towards CRISPR neutralization (Harrington et al., 2017) .
340
The challenge of neutralizing a pre-expressed CRISPR-Cas system likely explains why 341 stoichiometric inhibitors like Acr proteins are imperfect, and phages relying on them are 342 partially targeted by CRISPR. The sacrificial, population-level aspect of CRISPR 343 inhibition is reminiscent of the manifestations of CRISPR adaptation in populations of 344 bacterial cells. The majority of infected naïve host cells die, before a clone with a new 345 spacer emerges (Barrangou et al., 2007; Hynes et al., 2014) . In the case of anti-346 immunity, many phages die in order to inhibit CRISPR on a single cell level, and this 347 must happen at sufficient frequency within an ecosystem for phage to prevail. We 348 suspect that this mechanism of cellular immunosuppression and inter-parasite 
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At low parasite density, it is unlikely the cell will be re-infected and the host will survive.
555
As high parasite density, the likelihood that the immunosuppressed cell with be re-infected is higher. Co-or re-infection will lead to successful parasite replication and 557 amplification of the infectious population. Supplementary Figure 6 
